FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143313145> ?p ?o ?g. }

• W2143313145 endingPage "A36" @default.
• W2143313145 startingPage "A36.2" @default.
• W2143313145 abstract "<h3>Backgroundand objectives</h3> Autoimmunity in rheumatoid arthritis (RA) is characterised by autoantibodies to citrullinated proteins/peptides (ACPA). These antibodies, present in 60–70% of patients, antedate clinical onset and associate with an erosive disease course, suggesting a direct pathogenic involvement in disease initiation and progression. With this study, the authors aimed to develop an efficient method for the purification of human ACPA, and to characterise their frequency and fine-specificity pattern in synovial fluid (SF) and plasma of RA patients. <h3>Materials and methods</h3> SF and plasma samples were collected with informed consent and ethical approval from patients (fulfilling the American college of rheumatology criteria for RA) with high anti-CCP antibody levels. SF samples (n=36) were first treated with hyaluronidase to decrease viscosity, then proteins were precipitated with ammonium sulphate, dissolved and further dialysed against PBS, before the IgG fractions were purified on Protein G columns (GE Healthcare, Uppsala, Sweden).Plasma samples (n=10) were diluted in PBS before applied to the Protein G column. ACPAs were further purified using CCP2 affinity columns, kindly provided by Euro-Diagnostica. Recovery and purity of total IgG and anti-CCP immunoglobulin G (IgG) were analysed using SDS-PAGE, Nanodrop (Thermo Scientific, Wilmington, DE, USA) and the CCP2-ELISA kit. Fine-specificity of the purified ACPAs were investigated using inhouse ELISAs, with peptides from citrullinated α-enolase (CEP-1), -vimentin (Cit-vim), -fibrinogen (Cit-fib) and -collagen type II (Cit-C1). <h3>Results</h3> Anti-CCP IgG could efficiently be purified from SF and plasma, using ProteinG-, followed by CCP2-, columns. No CCP IgG response could be detected in the flow-through fractions. Higher concentrations of total IgG were found in plasma (13.6 mg/ml) compared to SF (4.2 mg/ml), while a higher percentage of CCP-specific IgG was detected in SF (3%), compared to plasma (2%). The purified anti-CCP IgG fractions cross-reacted with CEP-1, Cit-vim, Cit-fib and Cit-C1, while no reactivity to these citrullinated antigens were detected in the IgG flow-through fractions. Anti-CCP IgG dilution curves (starting at 10 µg/ml of purified antibodies), demonstrated differences in affinity between patients, which may correspond to the different ACPA-fine specificity patterns seen in patients. <h3>Conclusions</h3> The described methodology efficiently purifies ACPAs with multiple specificities, which will allow for their use in in vivo and in vitro studies, to further elucidate their arthritogenic and pathogenic capacity. In addition, the ACPAs will be tools for future immunoprecipitation-, immunoblotting- and immunohistochemistry experiments." @default.
• W2143313145 created "2016-06-24" @default.
• W2143313145 creator A5000515527 @default.
• W2143313145 creator A5015857642 @default.
• W2143313145 creator A5018144246 @default.
• W2143313145 creator A5025148001 @default.
• W2143313145 creator A5038205354 @default.
• W2143313145 creator A5046583167 @default.
• W2143313145 creator A5052621225 @default.
• W2143313145 creator A5066824201 @default.
• W2143313145 creator A5069378504 @default.
• W2143313145 creator A5071491614 @default.
• W2143313145 date "2012-02-01" @default.
• W2143313145 modified "2023-10-01" @default.
• W2143313145 title "Affinity purification and characterisation of human ACPAs" @default.
• W2143313145 doi "https://doi.org/10.1136/annrheumdis-2011-201234.11" @default.
• W2143313145 hasPublicationYear "2012" @default.
• W2143313145 type Work @default.
• W2143313145 sameAs 2143313145 @default.
• W2143313145 citedByCount "0" @default.
• W2143313145 crossrefType "journal-article" @default.
• W2143313145 hasAuthorship W2143313145A5000515527 @default.
• W2143313145 hasAuthorship W2143313145A5015857642 @default.
• W2143313145 hasAuthorship W2143313145A5018144246 @default.
• W2143313145 hasAuthorship W2143313145A5025148001 @default.
• W2143313145 hasAuthorship W2143313145A5038205354 @default.
• W2143313145 hasAuthorship W2143313145A5046583167 @default.
• W2143313145 hasAuthorship W2143313145A5052621225 @default.
• W2143313145 hasAuthorship W2143313145A5066824201 @default.
• W2143313145 hasAuthorship W2143313145A5069378504 @default.
• W2143313145 hasAuthorship W2143313145A5071491614 @default.
• W2143313145 hasBestOaLocation W21433131451 @default.
• W2143313145 hasConcept C126322002 @default.
• W2143313145 hasConcept C153911025 @default.
• W2143313145 hasConcept C159654299 @default.
• W2143313145 hasConcept C163764329 @default.
• W2143313145 hasConcept C185592680 @default.
• W2143313145 hasConcept C203014093 @default.
• W2143313145 hasConcept C2777575956 @default.
• W2143313145 hasConcept C3020134792 @default.
• W2143313145 hasConcept C43617362 @default.
• W2143313145 hasConcept C71924100 @default.
• W2143313145 hasConcept C86803240 @default.
• W2143313145 hasConceptScore W2143313145C126322002 @default.
• W2143313145 hasConceptScore W2143313145C153911025 @default.
• W2143313145 hasConceptScore W2143313145C159654299 @default.
• W2143313145 hasConceptScore W2143313145C163764329 @default.
• W2143313145 hasConceptScore W2143313145C185592680 @default.
• W2143313145 hasConceptScore W2143313145C203014093 @default.
• W2143313145 hasConceptScore W2143313145C2777575956 @default.
• W2143313145 hasConceptScore W2143313145C3020134792 @default.
• W2143313145 hasConceptScore W2143313145C43617362 @default.
• W2143313145 hasConceptScore W2143313145C71924100 @default.
• W2143313145 hasConceptScore W2143313145C86803240 @default.
• W2143313145 hasIssue "Suppl 1" @default.
• W2143313145 hasLocation W21433131451 @default.
• W2143313145 hasOpenAccess W2143313145 @default.
• W2143313145 hasPrimaryLocation W21433131451 @default.
• W2143313145 hasRelatedWork W1963734927 @default.
• W2143313145 hasRelatedWork W2043104746 @default.
• W2143313145 hasRelatedWork W2091280415 @default.
• W2143313145 hasRelatedWork W2101875571 @default.
• W2143313145 hasRelatedWork W2231748200 @default.
• W2143313145 hasRelatedWork W2394899461 @default.
• W2143313145 hasRelatedWork W2425255793 @default.
• W2143313145 hasRelatedWork W2428581596 @default.
• W2143313145 hasRelatedWork W3045746510 @default.
• W2143313145 hasRelatedWork W4283076837 @default.
• W2143313145 hasVolume "71" @default.
• W2143313145 isParatext "false" @default.
• W2143313145 isRetracted "false" @default.
• W2143313145 magId "2143313145" @default.
• W2143313145 workType "article" @default.